Developer site: The content shown here is test data.

MyEClinic
MyEClinic
Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.

Back to skin conditions

Congenital rubella syndrome secondary prevention

Introduction

Overview

Overview

Infants with congenital rubella syndrome should be placed in isolation during their hospital stay. In addition, appropriate measures should be taken to ensure that all healthcare workers and caregivers of the infected child are immune to rubella.[1]

Secondary Prevention

Secondary Prevention

Once an infant has been diagnosed with congenital rubella syndrome, the following precautionary measures should be taken into account:[1]

  • During the duration of the hospital stay, the infant should be isolated (i.e.: droplet and contact isolation)
  • All hospital contacts and caregivers of infant with congenital rubella syndrome should be ensured that they are immune to rubella virus
  • Because infants with congenital rubella syndrome are infectious for at least a period of 12 months, they may pose a risk for unimmunized children and pregnant women
  • Seronegative women should be offered the MMR vaccine in the postpartum period to reduce the risk of rubella infection and congenital rubella syndrome in subsequent pregnancies.[2]
References

References

  1. ↑ 1.0 1.1 Center for Disease Control and Prevention https://www.cdc.gov/vaccines/pubs/surv-manual/chpt15-crs.html. Accessed on Jan 17, 2017
  2. ↑ Watson JC, Hadler SC, Dykewicz CA, Reef S, Phillips L (1998). “Measles, mumps, and rubella–vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP)”. MMWR Recomm Rep. 47 (RR-8): 1–57. PMID 9639369.

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dima Nimri, M.D. [2]